Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

MXCT

Maxcyte (MXCT)

Maxcyte Inc
일자:
정렬 기준:
 검색 관련기사 보기:LSE:MXCT
일자시간출처헤드라인심볼기업
2018/09/2418:18Alliance NewsAlliance NewsMaxCyte Interim Revenue Rises But Loss Widens On CARMA DevelopmentLSE:MXCTMaxcyte Inc
2018/09/2415:01UK RegulatoryMaxCyte, Inc. Results for the Half Year ended 30 June 2018LSE:MXCTMaxcyte Inc
2018/09/1015:00UK RegulatoryMaxCyte, Inc. Grant of OptionsLSE:MXCTMaxcyte Inc
2018/09/0315:01UK RegulatoryMaxCyte, Inc. Notice of Half Year ResultsLSE:MXCTMaxcyte Inc
2018/07/2701:50Alliance NewsAlliance NewsDIRECTOR DEALINGS: Wife Of MaxCyte Non-Executive Director Buys SharesLSE:MXCTMaxcyte Inc
2018/07/2701:33UK RegulatoryMaxCyte, Inc. Director/PDMR ShareholdingLSE:MXCTMaxcyte Inc
2018/07/1619:49Alliance NewsAlliance NewsMaxCyte Gets US Clearance For Cancer Treatment TrialLSE:MXCTMaxcyte Inc
2018/07/1615:00UK RegulatoryMaxCyte, Inc. Trading UpdateLSE:MXCTMaxcyte Inc
2018/07/1615:00UK RegulatoryMaxCyte, Inc. FDA IND Clearance for First Clinical ProgrammeLSE:MXCTMaxcyte Inc
2018/06/1121:44Alliance NewsAlliance NewsMaxCyte Teams With US National Institutes To Treat Sickle Cell DiseaseLSE:MXCTMaxcyte Inc
2018/06/1115:00RNS Non-RegulatoryMaxCyte, Inc. MaxCyte & NIH enter CRADA for Sickle Cell DiseaseLSE:MXCTMaxcyte Inc
2018/05/2115:01RNS Non-RegulatoryMaxCyte, Inc. Preclinical Results at ASGCT Annual MeetingLSE:MXCTMaxcyte Inc
2018/04/3015:02UK RegulatoryMaxCyte, Inc. Notice of AGM and Annual ReportLSE:MXCTMaxcyte Inc
2018/04/2520:17Alliance NewsAlliance NewsMaxCyte Hires Claudio Dansky Ullmann As New Chief Medical OfficerLSE:MXCTMaxcyte Inc
2018/04/2515:01RNS Non-RegulatoryMaxCyte, Inc. CMO AppointmentLSE:MXCTMaxcyte Inc
2018/04/0420:10Alliance NewsAlliance NewsMaxCyte Revenue Up But Loss Widens On Investments In CARMA PlatformLSE:MXCTMaxcyte Inc
2018/04/0415:00UK RegulatoryMaxCyte, Inc. Final Results for Year Ended 31 December 2017LSE:MXCTMaxcyte Inc
2018/03/1516:01UK RegulatoryMaxCyte, Inc. Notice of Full Year ResultsLSE:MXCTMaxcyte Inc
2018/03/0103:04Alliance NewsAlliance NewsDIRECTOR DEALINGS: MaxCyte Non-Exec Chairman Thompson Sells SharesLSE:MXCTMaxcyte Inc
2018/03/0102:00UK RegulatoryMaxCyte, Inc. Director/PDMR ShareholdingLSE:MXCTMaxcyte Inc
2018/02/1516:01UK RegulatoryMaxCyte, Inc. Grant of OptionsLSE:MXCTMaxcyte Inc
2018/02/1322:36Alliance NewsAlliance NewsMaxCyte Appoints Ex-Genzyme Executive Richard Douglas Non-ExecutiveLSE:MXCTMaxcyte Inc
2018/02/1316:00UK RegulatoryMaxCyte, Inc. Dr Richard Douglas Joins MaxCyte BoardLSE:MXCTMaxcyte Inc
2018/02/0201:06UK RegulatoryMaxCyte, Inc. Block listing Interim ReviewLSE:MXCTMaxcyte Inc
2018/01/2322:32UK RegulatoryMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
2018/01/2223:34Alliance NewsAlliance NewsMaxCyte 2017 Earnings To Be In Line With Market ExpectationsLSE:MXCTMaxcyte Inc
2018/01/2216:00UK RegulatoryMaxCyte, Inc. Trading UpdateLSE:MXCTMaxcyte Inc
2018/01/1302:13UK RegulatoryMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
2017/12/0100:26UK RegulatoryMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
2017/10/3121:47UK RegulatoryMaxCyte, Inc. Result of AGMLSE:MXCTMaxcyte Inc
 검색 관련기사 보기:LSE:MXCT